DEALS ANALYSIS
Deals activity: South and Central America sees significant decrease in volume; deals down across sectors
Powered by
Deals activity by geography
Power industry deals, as captured by GlobalData’s Power Intelligence Centre, are down year-on-year (YoY) across all regions.
North America is leading in terms of deal value, but also recorded a significant decrease in YoY growth in deals volume at -11%. South and Central America, ranking last in terms of deal value, has also suffered the biggest YoY change, with deal volumes at -41%.
The volume of deals recorded by GlobalData also decreased YoY in Middle East and Africa (-16%), Europe (-11%), and Asia-Pacific (-11%).
Deals activity by type
| Deal type | Total deal value (US$m) | Total deal count | YoY change (volume) |
| Asset Transaction | 7258562 | 32302 | -26 |
| Debt Offering | 4165655 | 13047 | 23 |
| Acquisition | 2805297 | 12121 | 6 |
| Equity Offering | 1424002 | 7219 | -6 |
| Partnership | 106795 | 5787 | -51 |
| Venture Financing | 62455 | 4543 | -25 |
| Private Equity | 394926 | 2221 | -10 |
| Merger | 258696 | 358 | -97 |
A breakdown of deals by type and volume shows a general downtrend, with mergers down -97%, partnerships down -51%, and asset transactions down -26%. One bright spot was acquisitions' 6% growth. Financing deals have seen a similar downturn, with venture financing down -25% YoY and equity offerings down -6%, although debt offerings saw growth of 23%.
Deals activity by sector
The most notable development apparent in GlobalData’s analysis of power industry deals by sector is the decrease of deals across all sectors. Solar PV remained the leading sector by deals volume after several strong years of growth but also saw a decline of almost 400. Hydro saw the lowest decline in its total volume, with a drop of roughly 90.
Note: All numbers as of 02 December 2020. Deals captured by GlobalData cover M&As, strategic alliances, various types of financing and contract service agreements.
For more insight and data, visit GlobalData's Power Intelligence Centre.
Latest deals in brief
Irish energy group ESB acquires 50% stake in Inch Cape offshore wind farm
Irish energy group ESB has acquired a 50% ownership in the Inch Cape offshore wind farm from Scottish green energy supplier Red Rock Power for an undisclosed sum.
Goldwind Americas divests 160MW Rattlesnake Wind Project in Texas, US
OEM Goldwind Science & Technology subsidiary Goldwind Americas has sold its 160MW Rattlesnake Wind Project in McCulloch County, Texas, US, to an investment company advised by Exus Management Partners.
BlackRock acquires stake in US firm Distributed Solar Development
BlackRock Real Assets has acquired the remaining 20% stake in Distributed Solar Development (DSD) from GE Renewable Energy. DSD is a commercial and industrial solar developer and operator in the US.
UK’s TRIG acquires interest in 714MW East Anglia One wind farm
The UK-based Renewables Infrastructure Group (TRIG) has agreed to acquire a 14.3% indirect equity interest in the 714MW East Anglia One operational offshore wind farm from Green Investment Group (GIG).
For this acquisition, the investment applied to a 50% interest in the holding company through which GIG’s initial investment was made.
Copenhagen Infrastructure Partners acquires two hydro power projects in US
Danish investment firm Copenhagen Infrastructure Partners has announced the acquisition of two closed-loop pump storage hydro projects in the US on behalf of Copenhagen Infrastructure IV K/S.
Rhizen signs oncology drug development deal with Curon
Swiss biopharma company Rhizen Pharmaceuticals has signed an exclusive licensing agreement with Curon Biopharmaceutical to develop and commercialise Tenalisib for oncology in the Greater China region. Tenalisib, a highly selective dual PI3K delta and gamma inhibitor, is currently in Phase II clinical development for haematological malignancies. The US FDA granted fast track and orphan drug designations for the drug candidate Tenalisib as a treatment for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
